Myomo (MYO) Operating Margin Growth (5y) (2021 - 2025)
Myomo (MYO) Operating Margin Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn |
| 2 | Stryker | 126.93 Bn | 123.46 Bn | 4.50 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.40 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.69 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Myomo | 74.22 Mn | 55.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9,724.00 |
| Jun 30, 2025 | 28,421.00 |
| Mar 31, 2025 | 30,367.00 |
| Dec 31, 2024 | 16,768.00 |
| Sep 30, 2024 | 45,530.00 |
| Jun 30, 2024 | 29,259.00 |
| Mar 31, 2024 | 21,962.00 |
| Dec 31, 2023 | 25,630.00 |
| Sep 30, 2023 | 40,489.00 |
| Jun 30, 2023 | 40,562.00 |
| Mar 31, 2023 | 68,977.00 |
| Dec 31, 2022 | 27,658.00 |
| Sep 30, 2022 | 22,270.00 |
| Jun 30, 2022 | 55,169.00 |
| Mar 31, 2022 | 55,986.00 |
| Dec 31, 2021 | 413,594.00 |
| Sep 30, 2021 | 46,067.00 |
| Jun 30, 2021 | 18,728.00 |